Last reviewed · How we verify

Mannitol (Aridol) — Competitive Intelligence Brief

Mannitol (Aridol) (Mannitol (Aridol)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent / Diagnostic bronchial challenge agent. Area: Respiratory / Diagnostics.

marketed Osmotic agent / Diagnostic bronchial challenge agent Respiratory / Diagnostics Small molecule Live · refreshed every 30 min

Target snapshot

Mannitol (Aridol) (Mannitol (Aridol)) — University of Saskatchewan. Mannitol is an osmotic agent that draws fluid into the airways to increase airway hydration and mucus clearance, used diagnostically to assess airway hyperresponsiveness.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Mannitol (Aridol) TARGET Mannitol (Aridol) University of Saskatchewan marketed Osmotic agent / Diagnostic bronchial challenge agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent / Diagnostic bronchial challenge agent class)

  1. University of Saskatchewan · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Mannitol (Aridol) — Competitive Intelligence Brief. https://druglandscape.com/ci/mannitol-aridol. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: